Bradykinin attenuates glucagon-induced leucine oxidation in humans.
Trauma and injury are associated with accelerated protein loss. Counterregulatory hormones are possible mediators of this response. In the present study, the effect of glucagon and glucagon plus bradykinin on leucine and urea kinetics was examined in nine normal volunteers during somatostatin infusion and basal insulin replacement. Bradykinin was given because of its prostaglandin-stimulating qualities and the potential anabolic action of prostaglandins. Physiological hyperglucagonemia elicited a small but significant reduction of total leucine flux and rate of urea synthesis. Simultaneously, leucine oxidation increased by 70%. The simultaneous infusion of bradykinin did not alter glucagon-related changes in urea or leucine kinetics. Bradykinin, however, significantly attenuated the stimulation of leucine oxidation by glucagon. These results suggest that glucagon and tissue factors are involved in controlling leucine metabolism in humans.
Hartl
W H
WH
Shriners Burns Institute, Galveston, Texas.
Miyoshi
H
H
Jahoor
F
F
Klein
S
S
Elahi
D
D
Wolfe
R R
RR
D000328:Adult; D000596:Amino Acids / Q000378:metabolism*; D001920:Bradykinin / Q000494:pharmacology*; D002247:Carbon Isotopes; D005934:Glucagon / Q000494:pharmacology*; D006801:Humans; D007328:Insulin / Q000494:pharmacology*; D007700:Kinetics; D007930:Leucine / Q000378:metabolism*; D008297:Male; D010084:Oxidation-Reduction; D011994:Recombinant Proteins / Q000494:pharmacology; D013004:Somatostatin / Q000494:pharmacology; D014508:Urea / Q000378:metabolism
D000596:Amino Acids; D002247:Carbon Isotopes; D007328:Insulin; D011994:Recombinant Proteins; D013004:Somatostatin; D014508:Urea; D005934:Glucagon; D007930:Leucine; D001920:Bradykinin